Pantoprazole-induced hepatitis;Pantoprazol-induzierte hepatitis

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 12, 2003, Pages 611-614

  Cordes, Astrid ^a   Vogt, W ^a   Maier, K P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GASTROESOPHAGEAL REFLUX; HEPATITIS; HUMAN; LABORATORY TEST; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ABDOMEN; ABDOMINAL PAIN; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DIAGNOSIS, DIFFERENTIAL; ENZYME INHIBITORS; FEMALE; GASTROESOPHAGEAL REFLUX; HEPATITIS, TOXIC; HUMANS; LIVER; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; SULFOXIDES; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 0037459535     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38050     Document Type: Article

References (17)

1. Bashir RM, Lewis JH. Hepatotoxicity of drugs used in the treatment of gastrointestinal disorders. Gastroenterol Clin North Am 1995; 24: 937-967
2. Christe C, Stoller R, Kuhn M, Hartmann K. Medikamentöse Leberschädigungen und Protonenpumpenblocker. Schweiz Ärztezeitung 1998; 79: 1559
3. Christe C, Stoller R, Vogt N. Omeprazol-induced Hepatotoxity? A case report. Pharmacoepidemiology and Drug safety 1998; 7: 41-44
4. Collette D, Thürmann PA. Unerwünschte Arzneimittelwirkungen. Erbliche Unterschiede im Arzneistoffmetabolismus. Dtsch Med Wochenschr 2002; 127: 1025-1028
5. Creutzfeld W. Sind Protonenpumpeninhibitoren sicher? Internist 1994; 35: 1137-1146
6. Ferron GM, Preston RA, Noveck RJ et al. Pharmacokonetics of pantoprazole in patients with moderate and severe hepatic dysfunction. Clin Ther 2001; 23: 1180-1192
7. Garcia Rodriguez LA, Wallander MA, Stricker BH. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol 1997; 43: 183-188
8. Horn J. The proton-pump inhibitors: similarities and differences. Clin Ther 2000; 22: 266-280
9. Ishizaki T, Horai Y. Review article: Cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazol. Aliment Pharmacol Ther 1999; 13: 27-36
10. Jochem V, Kirkpatrick R, Greenson J, Brogan M, Sturgis T, Cook-Glenn C. Fulminant hepatic failure related to omeprazol. Am J Gastroenterol 1992; 87: 523-525
11. Koury SI, Stone CK, La Charite DD. Acute hepatitis induced by omeprazol. Am J Emergency Med 1998; 15: 550-551
12. Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England. Br J Clin Pharmacol 2000; 50: 366-372
13. Masubuchi N, Li AP, Okazaki O. An evaluation of the cytochrome P450 induction potential of pantoprazol in primary human hepatocytes. Chem Biol Interact 1998; 114: 1-13
14. Navarro JF, Gallego E, Aviles J. Recurrent severe acute hepatitis and omeprazole. Ann Int Med 1997; 127: 1135-1136
15. Romero-Gomez M, Otero MA, Suarez-Garcia E, Diaz EG, Fobelo MJ, Castro-Fernandez M. Acute Hepatitis related to omeprazol. AJG 1999; 94: 1119-1120
16. Stedman CAM, Barclay ML. Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963-978
17. Yusoff IF, Nairn P, Morgan CA. Multiple organ failure related to pantoprazole. Aust NZ J Med 1999; 29: 833-834